Hepatitis Monthly

Published by: Kowsar

Should We Rely on the Findings of Each Published Randomized Controlled Study?

Ali Kabir 1 , *
Author Information
1 Department of Epidemiology, Faculty of Public Health, Shahid Beheshti University of Medical Sciences, Center for Educational Research in Medical Sciences, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: March 01, 2013, 13 (3); e8355
  • Published Online: March 14, 2013
  • Article Type: Letter
  • Received: September 28, 2012
  • Accepted: October 15, 2012
  • DOI: 10.5812/hepatmon.8355

To Cite: Kabir A. Should We Rely on the Findings of Each Published Randomized Controlled Study?, Hepat Mon. 2013 ; 13(3):e8355. doi: 10.5812/hepatmon.8355.

Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Salt WB, 2nd. Nonalcoholic fatty liver disease (NAFLD): a comprehensive review. J Insur Med. 2004; 36(1): 27-41[PubMed]
  • 2. Hajiaghamohammadi AA, Ziaee A, Oveisi S, Masroor H. Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic Fatty liver disease: a randomized controlled pilot study. Hepat Mon. 2012; 12(8)[DOI][PubMed]
  • 3. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health. 1996; 86(5): 726-8[PubMed]
  • 4. The CONSORT Statement.
  • 5. Jamali R, Pourshams A, Amini S, Deyhim MR, Rezvan H, Malekzadeh R. The upper normal limit of serum alanine aminotransferase in Golestan Province, northeast Iran. Arch Iran Med. 2008; 11(6): 602-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments